A 19-year-old boy presented with signs of a granulomatous lung disease. Sputum testing for tuberculosis was negative. After a year, he returned with generalised lymphadenopathy. Though a clinical diagnosis of tuberculosis was then made and treatment was commenced, a lymph node biopsy revealed Langerhans cell histiocytosis. We are not aware of any other such case described in the Pacific.
AricóMGirschikofskyMGénéreauT, et al.Langerhans cell histiocytosis in adults: report from the International Registry of the Histiocyte Society. Eur J Cancer2003; 39: 2341–2348.
2.
BerresMLLimKPPetersT, et al.BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med2014; 211: 669–683.
3.
GirschikofskyMAricoMCastilloD, et al.Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis2013; 8: 72–72.
4.
World Health Organization. Country profile Vanuatu, http://apps.who.int/tb/data (2019, accessed February 2020).
5.
ArichaSA, et al.Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya. BMC Inf Dis2019; 19: 852–852.
